Duralast: Targeted Neuromodulation for Refractory Neuropathic Pain - An Evidence-Based Review

Product Description: Duralast is a non-invasive, wearable neuromodulation device designed for the management of chronic, refractory neuropathic pain syndromes, such as those resulting from diabetic peripheral neuropathy, post-herpetic neuralgia, and failed back surgery syndrome. It employs a proprietary, low-intensity focused pulsed electromagnetic field (PEMF) technology, calibrated to specific neural frequencies, to modulate aberrant pain signal transmission at the level of the dorsal root ganglion and central sensitization pathways. Unlike transcutaneous electrical nerve stimulation (TENS) units, which primarily target peripheral nerves with electrical current to block pain signals, Duralast’s mechanism is rooted in the principle of stochastic resonance and neural entrainment, aiming to restore a degree of normative neural oscillation patterns disrupted by chronic pain states.